Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
- PMID: 38810203
- DOI: 10.1056/NEJMc2404353
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Comment on
-
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical